相关实验视频
Updated: May 5, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.5K
致死性心肌病二次性至血清阴性免疫媒介性菌性肌病:一个病例报告
Benjamin D Lueck1, Alyssa K W Maclean1, Georges El Hasbani2
1Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
The American journal of case reports
|March 16, 2026
概括
一个罕见的致命心肌病在血清阴性免疫媒介性死性肌病 (IMNM) 中的罕见病例突显了心脏参与的不良预后. 为了在这个患者群体中获得有效的治疗方法,需要进一步的研究.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 异形性炎症性肌肉病 (IIM) 是一种自身免疫性肌肉疾病.
- 心脏参与在IIM中很罕见,通常会影响骨肌肉.
- 免疫媒介性死性肌肉病变 (IMNM) 是一种IIM亚型.
- 血清阴性IMNM缺乏特定的自身抗体,如抗SRP或抗HMGCR.
研究的目的:
- 报告一个进展性心肌病症的病例作为血清阴性IMNM的罕见并发症.
- 要突出与血清阴性IMNM中心脏参与相关的不良预后.
- 为了强调对这种疾病有效治疗的进一步研究的需要.
主要方法:
- 一个35岁的男性患有血清阴性IMNM的病例报告.
- 诊断工作包括肌肉活检,血清学检测,MRI和心脏成像 (PET,内心肌活检).
- 治疗涉及免疫抑制剂 (葡萄皮质激素,甲甲,IVIG,利图西马布,mycophenolate mofetil,cyclophosphamide) 和先进的心脏疗法.
主要成果:
- 患者出现肌肉虚弱和炎症标志物升高,诊断为IMNM.
- 尽管进行了积极的治疗,但患者患上了急性心力衰竭,心室性心力衰竭和渐进性心脏性休克.
- 心脏PET显示心肌炎症,心脏内膜活检显示纤维化和巨细胞.
结论:
- 致命的,不耐治疗的心肌病症可能是血清阴性IMNM的并发症.
- 在血清阴性IMNM中,临床心脏参与预示着预后不佳.
- 对血清阴性IMNM心脏参与的有效治疗策略仍未确定,需要进一步调查.
相关概念视频
Myocarditis I: Introduction
647
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
647
Myocarditis II: Clinical Features and Diagnostic Tests
496
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
496
Myocarditis III: Medical Management
344
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
344
Cardiomyopathy I: Introduction and Classification
828
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy IV: Restrictive Cardiomyopathy
957
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957

